Sequentially combined estradiol valerate plus levonorgestrel therapy decreases 18:1 trans-fatty acid content of plasma lipids in healthy postmenopausal women

Gynecological Endocrinology

Volumn 21, Issue 6, 2005, Pages 360-365

  Jokela, Hannu ^a   Kalela, Anne ^b   Lilja, Mari ^a   Salmi, Mia ^a,b   Lehtimäki, Terho ^a   Kunnas, Tarja ^b   Teisala, Klaus ^a   Punnonen, Reijo ^a   Nikkari, Seppo T ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

Author keywords

Hormone replacement therapy; Lipids; Trans fatty acids

Indexed keywords

CHOLESTEROL ESTER; ESTRADIOL VALERATE; ESTRADIOL VALERATE PLUS NORGESTREL; ESTROGEN; GESTAGEN; OLEIC ACID; PHOSPHOLIPID; TRANS FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET; FATTY ACID ANALYSIS; FEMALE; GAS CHROMATOGRAPHY; HORMONE SUBSTITUTION; HUMAN; LIPID BLOOD LEVEL; NORMAL HUMAN; PHOSPHOLIPID BLOOD LEVEL; POSTMENOPAUSE; PRIORITY JOURNAL; TRANS ISOMER;

ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; LEVONORGESTREL; LIPIDS; MIDDLE AGED; OLEIC ACID; POSTMENOPAUSE; TRANS FATTY ACIDS;

EID: 30344456701     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590500467361     Document Type: Article

References (22)

1. Slover HT, Thompson RH Jr, Davis CS, Merola GV. Lipids in margarines and margarine-like foods. J Am Oil Chem Soc 1985;62:775-786.
2. Position paper on trans fatty acids. ASCN/AIN Task Force on Trans Fatty Acids. American Society for Clinical Nutrition and American Institute of Nutrition. Am J Clin Nutr 1996;63:663-670.
3. Allison DB, Egan SK, Barraj LM, Caughman C, Infante M, Heimbach JT. Estimated intakes of trans fatty and other fatty acids in the US population. J Am Diet Assoc 1999;99:166-174.
4. Hulshof KF, van Erp-Baart MA, Anttolainen M, Becker W, Church SM, Couet C, Hermann-Kunz E, Kesteloot H, Leth T, Martins I, et al. Intake of fatty acids in Western Europe with emphasis on trans fatty acids: the TRANSFAIR Study. Eur J Clin Nutr 1999;53:143-157.
5. Zock PL, Mensink RP, Harryvan J, de Vries JH, Katan MB. Fatty acids in serum cholesteryl esters as quantitative biomarkers of dietary intake in humans. Am J Epidemiol 1997;145:1114-1122.
6. Vidgren HM, Louheranta AM, Agren JJ, Schwab US, Uusitupa MI. Divergent incorporation of dietary trans fatty acids in different serum lipid fractions. Lipids 1998;33:955-962.
7. Khosla P, Hayes KC. Dietary trans-monounsaturated fatty acids negatively impact plasma lipids in humans: critical review of evidence. J Am Coll Nutr 1996;15:325-339.
8. Aro A, Jauhiainen M, Partanen R, Salminen I, Mutanen M. Stearic acid, trans fatty acids, and dairy fat: effects on serum and lipoprotein lipids, apolipoproteins, lipoprotein(a), and lipid transfer proteins in healthy subjects. Am J Clin Nutr 1997;65:1419-1426.
9. Siguel EN, Lerman RH. Trans-fatty acid patterns in patients with angiographically documented coronary artery disease. Am J Cardiol 1993;71:916-920.
10. Willett WC, Stampfer MJ, Manson JE, Colditz GA, Speizer FE, Rosner BA, Sampson LA, Hennekens CH. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 1993;341:581-585.
11. Whitcroft SI, Crook D, Marsh MS, Ellerington MC, Whitehead MI, Stevenson JC. Long-term effects of oral and transdermal hormone replacement therapies on serum lipid and lipoprotein concentrations. Obstet Gynecol 1994;84:222-226.
12. Farish E, Spowart K, Barnes JF, Fletcher CD, Calder A, Brown A, Hart DM. Effects of postmenopausal hormone replacement therapy on lipoproteins including lipoprotein(a) and LDL subfractions. Atherosclerosis 1996;126:77-84.
13. De Kraker AT, Kenemans P, Smolders RG, Kroeks MV, van der Mooren MJ. The effects of 17β-oestradiol plus dydrogesterone compared with conjugated equine oestrogens plus medroxyprogesterone acetate on lipids, apolipoproteins and lipoprotein(a). Maturitas 2004;49:253-263.
14. Godsland IF. Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertil Steril 2001;75:898-915.
15. Van de Vijver LP, van Poppel G, van Houwelingen A, Kruyssen DA, Hornstra G. Trans unsaturated fatty acids in plasma phospholipids and coronary heart disease: a case-control study. Atherosclerosis 1996;126:155-161.
16. Van de Vijver LP, Kardinaal AF, Couet C, Aro A, Kafatos A, Steingrimsdottir L, Amorim Cruz JA, Moreiras O, Becker W, van Amelsvoort JM, et al. Association between trans fatty acid intake and cardiovascular risk factors in Europe: the TRANSFAIR study. Eur J Clin Nutr 2000;54:126-135.
17. Slattery ML, Benson J, Ma KN, Schaffer D, Potter JD. Trans-fatty acids and colon cancer. Nutr Cancer 2001;39:170-175.
18. Salmeron J, Hu FB, Manson JE, Stampfer MJ, Colditz GA, Rimm EB, Willett WC. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 2001;73:1019-1026.
19. Grodstein F, Martinez ME, Platz EA, Giovanucci E, Colditz GA, Kautzky M, Fuchs C, Stampfer MJ. Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Intern Med 1998;128:705-712.
20. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, Rosenberg CA, Taylor VM, Harris R, Chen C, et al.; Women's Health Initiative Investigators. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med. 2004;350: 991-1004.
21. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, et al. Writing group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. J Am Med Assoc 2002;288:321-333.
22. Mozaffarian D, Pischon T, Hankinson SE, Rifai N, Joshipura K, Willett WC, Rimm EB. Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 2004;79:606-612.